Position in SMMT
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$4,940,687
New position
Shares Held
339,100
first reported quarter
Ownership
0.043%
of shares outstanding
% of Portfolio
0.60%
of 13F equity value
Holder Rank
#47
of 242 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 16%
Shared 0%
None 84%
Position in Biotechnology
Healthcare · as of Jun 30, 2026HOHIMER WEALTH MANAGEMENT, LLC holds $8,657,709 across 7 Biotechnology names. SMMT ranks #1 (57.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SMMT |
Summit Therapeutics Inc.
This page
|
339,100 | $4,940,687 | |
| 2 | ACAD |
Acadia Pharmaceuticals Inc
|
91,800 | $2,322,540 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,530 | $759,996 | |
| 4 | KRYS |
Krystal Biotech, Inc.
|
1,038 | $385,793 | |
| 5 | INVA |
Innoviva, Inc.
|
9,505 | $215,858 | |
| 6 | ATYR |
aTYR PHARMA INC
|
55,000 | $32,835 | |
| 7 | 11,033 | $0 |
All Filings in SMMT
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,940,687 | 339,100 | Shares | Sole | 2026-08-03 | |
| No filing history on record for this holder in this stock. | ||||||